
1. cell microbiol. 2016 dec;18(12):1739-1750. doi: 10.1111/cmi.12608. epub 2016 may 
27.

breadth humoral response antigenic targets sporozoite-inhibitory
antibodies associated sterile protection induced controlled human malaria
infection.

peng k(1), goh ys(1), siau a(2), franetich jf(3)(4), chia wn(1)(5), ong as(1),
malleret b(1), wu yy(1), snounou g(3)(4), hermsen cc(6), adams jh(7), mazier
d(3)(4)(8), preiser pr(2), sauerwein rw(6), grüner ac(1), rénia l(1)(5).

author information: 
(1)laboratory pathogen immunobiology, singapore immunology network (sign),
agency science, technology research (a*star), biopolis, singapore.
(2)school biological sciences, nanyang technological university, singapore.
(3)centre d'immunologie et de maladies infectieuses (cimi) - paris, institut
national de la santé et de la recherche médicale (inserm) u1135 - centre national
de la recherche scientifique (cnrs) erl 8255, f-75013, paris, france.
(4)sorbonne universités, upmc univ paris 06, upmc umrs cr7, f-75005, paris,
france.
(5)department microbiology immunology, yong loo lin school medicine,
national university singapore, singapore.
(6)department medical microbiology, radboud university, nijmegen medical
center, nijmegen, netherlands.
(7)department global health, college public health, university south
florida, tampa, usa.
(8)ap hp, centre hospitalo-universitaire pitié-salpêtrière, f-75013, paris,
france.

the development effective malaria vaccine remained elusive even until
today. incomplete understanding immune mechanisms
that confer and/or correlate protection. human volunteers been
protected experimentally subsequent challenge immunization with
plasmodium falciparum sporozoites drug cover. here, demonstrate that
sera protected individuals contain neutralizing antibodies the
pre-erythrocytic stage. identify antigen(s) recognized these
antibodies, newly developed library p. falciparum antigens screened with
the neutralizing sera. antibodies protected individuals recognized broad
antigenic repertoire three antigens, pfmaebl, pftrap pfsea1 were
recognized protected individuals. proof principle, we
demonstrated anti-pfmaebl antibodies block liver stage development human 
hepatocytes. thus, antigens identified promising targets vaccine
development malaria.

© 2016 john wiley & sons ltd.

doi: 10.1111/cmi.12608 
pmcid: pmc5321637
pmid: 27130708  [indexed medline]

